![Peter Slover](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Slover
Director of Finance/CFO at
CONTINEUM THERAPEUTICS, INC.
Net worth: 45 084 $ as of 31/05/2026
Profile
Peter T.
Slover is Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. since 2020.
Formerly, Mr. Slover was Chief Financial & Accounting Officer at Sophiris Bio, Inc. from 2013 to 2020.
From 2009 to 2010, served as Chief Financial Officer, CAO & SVP-Operations at Anadys Pharmaceuticals, Inc. Worked as an Auditor at KPMG LLP from 1997 to 2004.
Completed undergraduate education at Shippensburg University of Pennsylvania in 1997.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/04/2026 | 3,342 ( 0.01% ) | 45 084 $ | 31/05/2026 |
Peter Slover active positions
| Companies | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2020 |
Former positions of Peter Slover
| Companies | Position | End |
|---|---|---|
| SOPHIRIS BIO | Director of Finance/CFO | 01/05/2020 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Director of Finance/CFO | - |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01/01/2004 |
Training of Peter Slover
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Shippensburg University of Pennsylvania
 Shippensburg University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
- Stock Market
- Insiders
- Peter Slover
